Dennis M. McGrath's most recent trade in PAVmed Inc was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on Sept. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PAVmed Inc | Dennis M. McGrath | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 150,000 | 200,834 (0%) | 0% | 0 | Common Stock | |
| Citius Oncology Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Citius Oncology Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Citius Oncology Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 300,000 | 300,000 | - | 0 | Common Stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 20,000 | 27,737 (1%) | 0% | 0 | Common Stock | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 300,000 | 1,343,569 | - | 0 | Common stock | |
| Citius Oncology Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharma Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Purchase Common Stock) | |
| Citius Oncology Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 400,000 | 1,043,569 | - | 0 | Common stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 80,000 | 154,744 (6%) | 3% | 0 | Common Stock | |
| Citius Pharma Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 28 Mar 2022 | 199,973 | 755,489 (1%) | 0% | 1.2 | 235,968 | Common stock |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 50,000 | 50,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 60,000 | 624,400 | - | 0 | Common stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Sale of securities on an exchange or to another person at price $ 17.11 per share. | 26 May 2021 | 45,773 | 51,630 (2%) | 2% | 17.1 | 783,144 | Common Stock |
| DarioHealth Corp | Dennis M. McGrath | Director | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 26 May 2021 | 22,014 | 29,616 (1%) | 0% | 16.7 | 368,039 | Common Stock |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 150,000 | 955,462 (2%) | 0% | 0 | Common Stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 29,616 | 97,403 | - | 0 | Restricted Stock Units |